Sickle cell disease treatment system and method
OwnerMichael Tarasevinventor
Life of this patent
Estimating the term…
Abstract
A method for treating sickle cell disease comprises removing blood from a patient with sickle cell disease, treating the removed blood to decrease the fraction of sickle-prone cells in the removed blood, and reintroducing the treated blood back into the patient. The treated blood that is reintroduced back into the patient has a reduced number of sickle-prone red blood cells when compared to the blood removed from the patient. In one version, the treatment of the blood includes inducing sickling of the red blood cells prone to sickle and then separating those sickled red blood cells from the blood before reintroducing the blood back into the patient.
Claims23
A method for treating sickle cell disease, the method comprising:
- removing blood from a patient with sickle cell disease;
- treating the removed blood to decrease the fraction of sickle-prone cells in the removed blood;
- and
- reintroducing the treated blood back into the patient,
- wherein the treated blood that is reintroduced back into the patient has a reduced number of sickle-prone red blood cells when compared to the blood removed from the patient.
A method for treating sickle cell disease, the method comprising:
- removing blood from a patient with sickle cell disease;
- inducing sickling of at least some sickle-prone cells in the removed blood;
- removing at least some sickled cells from the sickling-induced blood;
- and
- reintroducing the blood with the removed sickled cells back into the patient.
A sickle cell disease treatment system comprising:
- a line adapted to receive blood from a patient;
- a blood treatment unit in communication with the line adapted to receive blood from a patient, the blood treatment unit comprising:
- a sickling inducement unit adapted to receive blood from the patient and induce sickling of sickle-prone cells in the blood from the patient;
- and
- a sickled cell separation unit adapted to remove sickled cells from the blood received from the sickling inducement unit;
- and
- a line adapted to reintroduce treated blood from the blood treatment unit back into the patient,
- wherein the reintroduced blood has a reduced number of sickle-prone red blood cells when compared to the blood removed from the patient.
Dependencies are inferred from the claim text.